Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ami Miller

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Scientific Reports|May 19, 2021
Implementing a method for engineering multivalency to substantially enhance binding of clinical trial anti-SARS-CoV-2 antibodies to wildtype spike and variants of concern proteinsAdam Leach, Ami Miller, Emma Bentley, et al.
Elife|December 12, 2025
Degradation of LMO2 in T cell leukaemia results in collateral breakdown of transcription complex partners and causes LMO2-dependent apoptosisNaphannop Sereesongsaeng, Carole Bataille, Angela Russell, et al.
Leukemia Research|June 1, 2021
An antibody-drug conjugate with intracellular drug release properties showing specific cytotoxicity against CD7-positive cellsJing Zhang, Arvind Jain, Sabine Milhas, et al.
Journal of Molecular Biology|March 15, 2011
Zinc binding to the Tyr402 and His402 allotypes of complement factor H: possible implications for age-related macular degenerationRuodan Nan, Irene Farabella, Felix F Schumacher, et al.
Antiviral Research|August 10, 2021
A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potencyAdam Leach, F Tudor Ilca, Zulaikha Akbar, et al.
Science Advances|April 10, 2021
A cell-based screening method using an intracellular antibody for discovering small molecules targeting the translocation protein LMO2Nicolas Bery, Carole J R Bataille, Angela Russell, et al.
The Journal of Biological Chemistry|October 28, 2015
Structure-based Discovery of Novel Small Molecule Wnt Signaling Inhibitors by Targeting the Cysteine-rich Domain of FrizzledHo-Jin Lee, Ju Bao, Ami Miller, et al.
Scientific Reports|April 10, 2019
Surfaceome interrogation using an RNA-seq approach highlights leukemia initiating cell biomarkers in an LMO2 T cell transgenic modelHelio Pais, Katia Ruggero, Jing Zhang, et al.
Elife|July 11, 2018
BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactionsNicolas Bery, Abimael Cruz-Migoni, Carole Jr Bataille, et al.
Acta Crystallographica. Section F, Structural Biology Communications|March 3, 2018
Cloning, purification and structure determination of the HIV integrase-binding domain of lens epithelium-derived growth factorClare Hannon, Abimael Cruz-Migoni, Olga Platonova, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Scientific Reports|May 19, 2021
Implementing a method for engineering multivalency to substantially enhance binding of clinical trial anti-SARS-CoV-2 antibodies to wildtype spike and variants of concern proteinsAdam Leach, Ami Miller, Emma Bentley, et al.
Elife|December 12, 2025
Degradation of LMO2 in T cell leukaemia results in collateral breakdown of transcription complex partners and causes LMO2-dependent apoptosisNaphannop Sereesongsaeng, Carole Bataille, Angela Russell, et al.
Leukemia Research|June 1, 2021
An antibody-drug conjugate with intracellular drug release properties showing specific cytotoxicity against CD7-positive cellsJing Zhang, Arvind Jain, Sabine Milhas, et al.
Journal of Molecular Biology|March 15, 2011
Zinc binding to the Tyr402 and His402 allotypes of complement factor H: possible implications for age-related macular degenerationRuodan Nan, Irene Farabella, Felix F Schumacher, et al.
Antiviral Research|August 10, 2021
A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potencyAdam Leach, F Tudor Ilca, Zulaikha Akbar, et al.
Science Advances|April 10, 2021
A cell-based screening method using an intracellular antibody for discovering small molecules targeting the translocation protein LMO2Nicolas Bery, Carole J R Bataille, Angela Russell, et al.
The Journal of Biological Chemistry|October 28, 2015
Structure-based Discovery of Novel Small Molecule Wnt Signaling Inhibitors by Targeting the Cysteine-rich Domain of FrizzledHo-Jin Lee, Ju Bao, Ami Miller, et al.
Scientific Reports|April 10, 2019
Surfaceome interrogation using an RNA-seq approach highlights leukemia initiating cell biomarkers in an LMO2 T cell transgenic modelHelio Pais, Katia Ruggero, Jing Zhang, et al.
Elife|July 11, 2018
BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactionsNicolas Bery, Abimael Cruz-Migoni, Carole Jr Bataille, et al.
Acta Crystallographica. Section F, Structural Biology Communications|March 3, 2018
Cloning, purification and structure determination of the HIV integrase-binding domain of lens epithelium-derived growth factorClare Hannon, Abimael Cruz-Migoni, Olga Platonova, et al.
Pageof 3